[(Oestrogen receptor,is,expressed,1.0), (Oestrogen receptor,is expressed in,approximately 60 %,1.0)][(Oestrogen receptor,is,expressed,1.0), (Oestrogen receptor,is expressed in,approximately 60 %,1.0)]
[(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)][(tumours,are,more tolerant,1.0), (ER-positive tumours,are tolerant than,ER-negative,1.0), (ER-positive tumours,are,tolerant,1.0), (tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are more tolerant than,ER,1.0), (tumours,are tolerant to,drug resistance,1.0), (ER-positive tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER-negative,1.0), (tumours,are tolerant than,ER-negative,1.0), (tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,drug resistance,1.0), (tumours,are,more tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (ER-positive tumours,are tolerant than,ER,1.0), (ER-positive tumours,are tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (ER-positive tumours,are,more tolerant to chemotherapeutic drug resistance than ER-negative,1.0), (tumours,are,tolerant to drug resistance than ER-negative,1.0), (ER-positive tumours,are more tolerant than,ER,1.0), (tumours,are tolerant than,ER,1.0), (ER-positive tumours,are,tolerant to drug resistance than ER-negative,1.0), (tumours,are more tolerant to,chemotherapeutic drug resistance,1.0), (tumours,are more tolerant than,ER-negative,1.0), (tumours,are,tolerant,1.0), (ER-positive tumours,are,more tolerant,1.0), (tumours,are more tolerant to,drug resistance,1.0), (ER-positive tumours,are tolerant to,drug resistance,1.0)]
[(isobavachalcone,is known In,addition,1.0), (isobavachalcone,is,known,1.0), (kind,is with,antitumour effect,1.0)][(isobavachalcone,is known In,addition,1.0), (isobavachalcone,is,known,1.0), (kind,is with,antitumour effect,1.0)][(isobavachalcone,is known In,addition,1.0), (isobavachalcone,is,known,1.0), (kind,is with,antitumour effect,1.0)]
[(underlying mechanism,is in,ER cancer,1.0)]
[(IBC,attenuate,17Î²-estradiol,1.0)]
